We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medtronic Violated cGMPs in Making Infusion Pumps, FDA Says
Medtronic Violated cGMPs in Making Infusion Pumps, FDA Says
October 5, 2006
A recent FDA warning letter to Medtronic's neurological division cited the company for a slew of current good manufacturing practice (cGMP) violations. The FDA posted the letter to its website Sept. 12.